Showing papers in "Sleep Medicine in 2006"
••
TL;DR: These findings confirm the high prevalence of insomnia in the general population, while few insomnia sufferers seek professional consultations, many individuals initiate self-help treatments, particularly when daytime impairments such as fatigue become more noticeable.
958 citations
••
TL;DR: The analysis of the electromyogram (EMG) signal and of the periodicity of the phenomenon provides different methods for the evaluation of muscle activity in normal and pathological sleep.
447 citations
••
TL;DR: Those with Daily RLS symptoms had statistically more frequent excessive daytime sleepiness, poorer self-reported general health, an elevation in depressive and anxiety symptoms, and an increased prevalence of cardiovascular disease compared to those with no RLS Symptoms.
283 citations
••
TL;DR: Ramelteon demonstrated a statistically significant reduction in LPS and a statisticallysignificant increase in TST, with no apparent next-day residual effects, in patients with chronic primary insomnia.
258 citations
••
TL;DR: In older adults with chronic insomnia, ramelteon significantly reduced patient reports of sleep latency over five weeks of treatment with no significant rebound insomnia or withdrawal effects.
237 citations
••
TL;DR: The current MRI results in combination with previous autopsy data support the role of low brain iron in the SN in at least those with early-onset RLS symptoms.
234 citations
••
TL;DR: The results indicate that RLS patients show cognitive deficits similar to that reported for one night of sleep loss, which is similar to those seen with acute sleep deprivation.
188 citations
••
TL;DR: Mild to moderate OSAH has little impact on the selected measures of attention, executive function, motor speed and processing speed, however, hypoxemia adversely affects both motor andprocessing speed.
151 citations
••
TL;DR: TBI patients with insomnia have a tendency to overestimate their sleep disturbance compared to PSG measures of sleep, similar to those found in patients with either primary insomnia or insomnia related to depression.
150 citations
••
TL;DR: Pramipexole is effective and safe in the treatment of both objective and subjective facets of RLS and did not produce somnolence at any dose.
145 citations
••
TL;DR: Benefits of short-term treatment included signs of reduced insulin resistance and improved QoL, however, in this population-based sample compliance with CPAP was very low.
••
TL;DR: A short nap is favorable for consolidation of procedural memory and Females showed more improvement than males in the declarative memory tasks irrespective of nap or wake.
••
TL;DR: It is proposed that hypoxic arousals may have a more severe impact on sleep architecture in patients with OSA than non-hypoxic arousal and caused overall deficits in the EEG delta power of NREMS and marked deficits inThe total amount of REMS.
••
TL;DR: An investigation of CAP in sleepwalkers demonstrated the presence of an abnormal CAP rate with a decrease in phase A1 and an increase in phases A2 and A3 on non-sleepwalking nights.
••
TL;DR: Zolpidem-MR 12.5mg is effective and safe in treating primary insomnia in adults and improves sleep maintenance, induction and duration of sleep.
••
TL;DR: Items relating to the child's sleep behaviors, environment, and parents' perceptions were predictive of positive report of snoring, with snoring rates consistent with a significant risk for sleep-disordered breathing being similar to those reported for older children.
••
TL;DR: Pramipexole markedly reduced the frequency and severity of RBD symptoms and appeared to maintain efficacy for up to 25 months as assessed at follow-up visits.
••
TL;DR: The IRLS total score, symptoms, and symptoms impact subscales are reliable, valid, and responsive in a clinical trial setting, indicating known groups and clinical validity, respectively.
••
TL;DR: Findings indicate that certain sleep complaints are common among ANX, and the need for appropriate assessment practices is discussed, though rates for specific items varied.
••
TL;DR: CompSAS patients have more CPAP interface problems and require more follow-up than OSAS patients but with intervention may have similar treatment results compared to patients with OSAS.
••
TL;DR: Results support a continuum of sleepiness/alertness among PWI and Receiver operating characteristic (ROC) curve analysis proved the ESS to discriminate poorly between P WI and PNI.
••
TL;DR: Normal sleepers with an identified vulnerability to stress-induced sleep disturbance exhibited greater objectively verifiable sleep-reactivity in response to a caffeine challenge compared to non-vulnerable individuals, suggesting that the construct of individual differences in vulnerability to sleep disturbance applies to a pharmacological 'stressor' as well as to previously assessed stressors.
••
••
TL;DR: In Greek subjects with OSAS, there was no difference in BMI, and female patients were significantly older than male patients, but several aspects of sleep were worse in women versus men.
••
TL;DR: Age, BMI, hypertension (HT), AHI, and REI were found to be significantly associated with nocturia, while Nocturia was reported significantly more by severe SDB patients.
••
TL;DR: Temperament and sleep are important factors influencing school achievement, and their assessment could help to identify children at risk regarding school achievement.
••
TL;DR: The greater diurnal changes in RLS suggest greater fluctuations than normal in DAergic circadian dynamics, and the increased 3OMD concentration in the absence of concurrent exogenous levodopa (l-dopa) suggests changes in synthesis or metabolism of l- dopa in R LS.
••
TL;DR: HT is more effective than CP to improve TST and to decrease TNT in FM patients, and QOL improved for the two groups in all domains when pre- and post-intervention were compared, but there was no difference between groups.
••
TL;DR: Reversible SDB is common among patients with primary hypothyroidism and changes in upper airway anatomy resulting from hyp Timothyroidism probably contribute to the development of SDB in these patients.
••
TL;DR: RLS is comparably prevalent among African-American and Caucasian adults in the general population and barriers affecting access to care settings for African- American RLS patients should be investigated in the future.